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Antisera raised against the carboxy-terminal decapeptide (KENLKDCGLF) of transducin-a detected the 
40 kDa, major pertussis toxin substrate of human neutrophils. The antisera also detected this protein in 
undifferentiated HL-60 and U937 cells, and revealed an approx. 2-fold increase in protein/mg membrane 
protein with differentiation into mature phagocytic cells. The results provide direct immunochemical evi- 
dence for the presence of a novel, pertussis toxin-sensitive guanine nucleotide-binding protein in human leu- 
kocytes. 
GTP-bindingprotein Signal transduction Phosphoinositide breakdown 
1. INTRODUCTION 
Neutrophils contain large amounts (at least 20 
pmol/mg membrane protein) of an approx. 40 
kDa pertussis substrate [l]. This pertussis toxin- 
sensitive guanine nucleotide-binding protein (G- 
protein) couples the chemotactic peptide receptor 
to phosphoinositide (PI) breakdown [2,3]. It was 
initially assumed that the neutrophil protein is Gi, 
the G-protein associated with inhibition of 
adenylate cyclase, since Gi was the first pertussis 
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Abbreviations: G-protein, guanine nucleotide-binding 
protein; G, and Gr, the G-proteins associated with 
stimulation and inhibition, respectively, of adenylate 
cyclase; G,, a G-protein of unknown function 
discovered in brain; TD, transducin, the G-protein of 
retinal rod outer segments; PI, phosphoinositide; fMet- 
Leu-Phe, N-formylmethionylleucylphenylalanine; SDS- 
PAGE, SDS-polyacrylamide gel electrophoresis 
toxin substrate to be identified [2]. Subsequently, 
other pertussis toxin substrates have been de- 
scribed, including transducin (TD), the G-protein 
of photoreceptor cells, and G,, a G-protein of 
unknown function discovered in brain [4,5]. Using 
specific antisera directed against TD and G, and a 
TD antiserum that crossreacts with Gt in brain, we 
found that these G-proteins are present in insuffi- 
cient amounts to account for the pertussis toxin 
substrate in neutrophils [l]. On this basis, we sug- 
gested that neutrophils contain a novel G-protein 
as the major pertussis toxin substrate. With newly 
developed antisera raised against synthetic pep- 
tides, we now provide direct immunochemical 
evidence for the presence of this novel G-protein in 
neutrophils and cultured leukocyte cell lines. 
2. MATERIALS AND METHODS 
2.1. Cells 
Human neutrophils were purified from 
peripheral venous blood of normal volunteers by 
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Ficoll-Hypaque density centrifugation and dex- 
trose sedimentation with hypotonic lysis of 
residual erythrocytes [6]. HL-60, a human pro- 
myelocyte line [7], and U937, a human monocyte 
line [S], were maintained in RPM1 1640 medium 
supplemented with 2 mM glutamine and 10% fetal 
bovine serum. Both cell lines were induced to dif- 
ferentiate into more mature phagocytic cells by the 
addition of 750 PM N6, @-dibutyryladenosine 
3 ‘,5’-monophosphate to the culture medium for 3 
days [9,10]. 
2.2. Membrane preparations 
A neutrophil plasma membrane-enriched frac- 
tion was prepared by nitrogen cavitation of 
neutrophils, low-speed centrifugation to remove 
nuclei, and ultracentrifugation into a Percoll gra- 
dient [ 111. Washed uninduced and induced HL-60 
and U937 cells were subjected to nitrogen cavita- 
tion, and low-speed centrifugation as for 
neutrophils [ 111. The supernate, however, was cen- 
trifuged at 100000 x g for 45 min to obtain a par- 
ticulate fraction which was used without further 
purification. A crude plasma membrane prepara- 
tion from human cerebral cortex was prepared as 
described [12]. 
2.3. Pertussis toxin labeling 
Pertussis toxin (kindly provided by Dr J. 
Munoz, Rocky Mountain Laboratories, NIAID) 
was activated by incubating 1 mg/ml pertussis tox- 
in in 100 mM Tris buffer, pH 8.0, with 50 mM 
dithiothreitol for 15 min at room temperature. A 
volume of membrane protein (2-5 mg/ml) was 
mixed with an equal volume of a reaction mixture 
containing 70 pg/ml activated pertussis toxin, 
200 mM Tris buffer, pH 8.0, 4 mM ATP, 2 mM 
GTP, 2 mM ADP-ribose, 20 mM nicotinamide, 
and 10pM NAD containing [a-32P]NAD at a 
specific activity of 22.8 Ci/mmol (New England 
Nuclear) and incubated for 1 h at 37°C. Controls 
were incubated with the same reaction mixture 
minus pertussis toxin. The reaction was terminated 
by addition of SDS sample buffer in preparation 
for SDS-PAGE [6]. Gels were stained with 
Coomassie blue, dried and subjected to autoradio- 
graphy using image intensification screens with 
Kodak X-AR film at -70°C. 
2.4. Immunoblots 
The following antisera were used as first anti- 
bodies: RV3, specific for G,-Q and -,f3 [12]; CW6, 
raised against holotransducin but crossreacting 
with Gi+ in brain and erythrocyte [13]; A-569 
raised against a synthetic peptide common to all 
known G-Q subunits [14]; AS6, 7 and 8, each 
raised against the carboxy-terminal decapeptide of 
TD (KENKLDCGLF), conjugated to keyhole 
limpet hemocyanin with glutaraldehyde. Im- 
munoblotting and affinity purification of an- 
tibodies were performed as in [l, 121. For A4, 
estimations on immunoblots, prestained Mr 
markers (Bethesda Research Labs) were run in 
parallel with test samples. 
3. RESULTS 
Both brain and neutrophils are known to con- 
tain high concentrations of pertussis toxin sub- 
strates [ 11. In brain these are largely accounted for 
by G, and Gi, present in a ratio of about 5 : 1 [ 121. 
Antisera RV3 and CW6 readily detect the a-sub- 
units of G, and Gi, respectively, in brain. Both an- 
tisera detect the common &subunit [l, 121. In 
neutrophils, despite the high concentration of per- 
tussis toxin substrate measured by toxin-catalyzed 
incorporation of [32P]ADP-ribose, we failed to 
detect immunoreactive G,- or TD-cz [ 11. Immuno- 
reactive Gi* was detected with CW6 but in 
amounts insufficient to account for the total con- 
centration of neutrophil pertussis toxin substrate. 
We therefore tested both human neutrophil and 
cerebral cortical plasma membranes with new anti- 
sera raised against the carboxy-terminal decapep- 
tide of TD-cu, KENLKDCGLF. These antisera 
react strongly with TD-cu and with Gie subunits 
purified from several tissues. This presumably 
reflects the similarity in sequence between TD-(Y 
and Gi+ (KNNLKDCGLF) [ 151. The antisera 
react poorly if at all with Go+ which diverges by 
5110 amino acids of the decapeptide [16]. 
Fig.1 shows that RV3 detects a broad, approx. 
39 kDa band representing G,_(y in brain but shows 
no reactivity in neutrophil. CW6 detects a band 
with slightly slower migration in both brain and 
neutrophil. The common P-subunit is detected by 
both antisera in both tissues. Affinity-purified 
anti-peptide antibodies (AS7) were diluted to give 
comparable reactivity to that obtained with CW6 
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Fig.1. Immunoblots of human cerebral cortical (brain) 
and human neutrophil (WBC) membranes. 100 @g/lane 
of plasma membranes were loaded on a 10% SDS gel, 
separated by SDS-PAGE, and immunoblotted with anti- 
sera: (1) RV3, specific for G,-cu and -fl; (2) CW6, specific 
for Gr+ and -/3; (3) AS7, raised against the carboxy- 
terminal decapeptide of transducin-cu. For RV3 and 
AS7, affinity-purified antibodies, diluted l/20 and l/10, 
respectively, were used. For CW6, a l/100 dilution of 
crude antiserum was used. The band above G>-cY in lane 
2 represents nonspecific reactivity of the crude anti- 
serum. 
in brain (fig.1, left, lanes 2,3). The identical dilu- 
tion of AS7, in contrast, showed substantially 
more immunoreactivity in neutrophil than did 
CW6 (fig.1, right, lanes 2,3). Comparable results 
were obtained with the two other anti-decapeptide 
sera (AS6,8) that we produced. An antiserum 
(A-569) against a peptide common to all G-cu 
subunits [14] also showed strong reactivity with a 
40 kDa band in neutrophils (not shown). 
Certain cultured leukocyte lines such as HL-60 
and U937 can be induced to differentiate into 
mature phagocytic cells responsive to the chemo- 
tactic peptide, fMet-Leu-Phe. Pertussis toxin in- 
hibits chemotactic peptide stimulation in differ- 
entiated HL-60 cells [ 171. This suggests that these 
cells contain a G-protein functionally equivalent o 
that in mature neutrophils. The uninduced cells 
used in our study did not express detectable fMet- 
Leu-Phe receptors, either by binding assays with 
tritiated peptide or by photoaffinity labeling, nor 
did the cells respond chemotactically to fh4et-Leu- 
Phe [6,10,18]. Differentiated cells showed a 
decrease in size, a marked increase in spontaneous 
motility in culture, expressed fMet-Leu-Phe recep- 
tors, and responded chemotactically to this pep- 
tide. Differentiated U937 cells showed an increase 
in nonspecific esterase activity consistent with 
maintenance of a monocyte phenotype, while the 
differentiated HL-60 cells remained free of non- 
specific esterase activity. 
For pertussis toxin labeling and immunoblotting 
experiments, we loaded plasma membranes from 
equivalent numbers of uninduced and induced cells 
on each SDS gel lane. Since cells induced to dif- 
ferentiate decreased in size, lower amounts of 
membrane protein from induced cells were loaded 
per lane compared with uninduced cells (see fig.2 
legend). A number of bands were seen on auto- 
radiograms of HL-60 and U937 cell membranes ex- 
posed to [32P]NAD, but a single band of about 
40 kDa (labeled LY in fig.2) was labeled in a toxin- 
dependent manner in each set of membranes. The 
HL-60 
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Fig.2. Detection of substrates for pertussis toxin- 
catalyzed ADP-ribosylation in HL-60 and U937 cell 
membranes. Plasma membranes from undifferentiated 
(C) cells, and from cells induced to differentiate (I) were 
incubated with [32P]NAD and with (+) or without (-) 
pertussis toxin as described in section 2. Membranes 
were then loaded on a 10% SDS gel (HL-60, 
I = 77 pg/lane, C = 139 pg/lane; U937, I = 105 pg/ 
lane, C = 185 pg/lane). An autoradiogram of the dried 
gel is shown. 
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Fig.3. Immunoblots of plasma membranes from dif- 
ferentiated (I) and undifferentiated (C) HL-60 and U937 
cells. Membranes (protein amounts identical to those in 
fig.2) were loaded on a 10% SDS gel and separated by 
SDS-PAGE. Immunoblotting was performed with: (A) a 
l/100 dilution of antiserum AS7; (B) a l/1000 dilution 
of antiserum A-569, raised against the peptide common 
to G-CY subunits. In (B) only, radioiodinated goat anti- 
rabbit Ig was used as second antibody and an autoradio- 
gram (overnight exposure) of the exposed blot is shown. 
amount of [32P]ADP-ribosylated toxin substrate 
was comparable in induced and uninduced U937 
cells and only slightly increased in induced HL-60 
cells when compared on a cell equivalent basis. Per 
mg membrane protein, however, there was an ap- 
proximate doubling in toxin substrate concentra- 
tion with differentiation in both cell types. 
Antisera RV3 and CW6 both detected P-subunit 
but minimal G,- or G~-cY subunit reactivity in in- 
duced and uninduced HL-60 and U937 cells. In 
contrast all three anti-decapeptide antisera 
(AS6,7,8) reacted strongly with a 40 kDa band 
(not shown). Fig.3 shows the results of an im- 
munoblot with one of the decapeptide antisera 
(AS7) and with the common G-CY peptide anti- 
serum. Each antiserum reacts with the identical, 
approx. 40 kDa band (labeled cy in fig.3). The 
amount of immunoreactivity in equivalent 
numbers of induced vs uninduced cells is not clear- 
ly different in U937 cells, but in HL-60 cells there 
is a definite increase with differentiation. When ex- 
pressed per mg membrane protein, detectable im- 
munoreactivity increases by at least a factor of 2 
with differentiation of both cell types. 
4. DISCUSSION 
Our results represent he first immunochemical 
detection of pertussis toxin substrate in neutrophils 
and cultured leukocyte cell lines. The ability of an 
antiserum raised against a peptide common to all 
known G-Q subunits to detect the neutrophil per- 
tussis toxin substrate is not surprising, since all 
specific pertussis toxin substrates identified to date 
are G-CY subunits. Detection of the neutrophil pro- 
tein with antisera raised against the carboxy- 
terminal decapeptide of TD_(y, however, provides 
direct evidence for the existence of a novel per- 
tussis toxin substrate in neutrophils. The 
neutrophil substrate presumably contains a se- 
quence identical to, or highly homologous to, the 
KENLKDCGLF or KNNLKDCGLF sequence 
with which the antisera strongly react. The com- 
parable sequence of Go+, ANNLRGCGLY, is 
poorly recognized by the decapeptide antisera. 
Thus G, cannot account for the immunoreactivity 
detected with AS6-8. Although TD-a does contain 
the appropriate sequence, the neutrophol substrate 
must differ from TD-Q since several TD-specific 
antisera fail to react with neutrophil membranes 
[ 11. Our results clearly show that decapeptide anti- 
sera recognize a form of pertussis toxin substrate 
in neutrophils different from the 41 kDa form of 
Gi+ in brain recognized by antiserum CW6. Thus, 
the neutrophil protein (or possibly proteins) shares 
a highly homologous decapeptide sequence with 
TD- and 41 kDa Gi+ but must differ from these 
proteins in one or more other regions, including 
the epitope recognized by antiserum CW6. 
Recent cloning of cDNAs for multiple G-cr sub- 
units suggests the existence of as many as three dif- 
ferent forms of Gi+ ([15,16]; Reed, R. and Jones, 
D., personal communication). Two of these con- 
tain the KNNLKDCGLF sequence and one the 
KENLKDCGLF sequence, so that all three should 
be detected with our decapeptide antisera. The 
tissue distribution of these distinct forms of G/is 
not known, but our data suggest that qualitative 
and/or quantitative differences in distribution may 
occur in brain and neutrophil. The finding that the 
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pertussis toxin substrate in various types of white 
cells is also sensitive to cholera toxin may represent 
another distinguishing feature between the 
neutrophil G-protein and the pertussis toxin sub- 
strates of brain [ 191. The functional significance, if 
any, of subtle differences in amino acid sequence 
between different forms of Gi+ is not known. 
Kikuchi et al. [20] have found that both Gi and G,, 
purified from brain, could reconstitute fMet-Leu- 
Phe stimulated PI breakdown in pertussis toxin 
treated HL-60 cells. This may indicate that any 
form of Gi and indeed even G, can substitute for 
the endogenous neutrophil pertussis toxin sub- 
strate, but it remains possible that functional dif- 
ferences do exist. 
The immunoblot data indicate that a protein 
identical or very closely related to the pertussis tox- 
in substrate of mature neutrophils is present in 
cultured leukocyte cell lines such as HL-60 and 
U937. Interestingly, this protein is already de- 
tectable in undifferentiated cells. With differentia- 
tion there is at least a 2-fold increase in con- 
centration of the protein/mg membrane protein as 
shown by both toxin labeling and immunoblotting. 
At present it is not clear if this increase represents 
de novo synthesis of protein, altered turnover, or 
both. Further studies with differentiating leuko- 
cyte lines may prove useful in helping to identify 
the pertussis toxin substrate of neutrophils. 
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